๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Immunological monitoring of the tumor immunoenvironment for clinical trials

โœ Scribed by Anatoli M. Malyguine; Susan L. Strobl; Michael R. Shurin


Book ID
105967988
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
226 KB
Volume
61
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Design of clinical trials for recurrent
โœ Shigeyuki Matsui; Hideaki Miyagishi ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB ๐Ÿ‘ 2 views

This paper presents a design for randomized clinical trials in which incomplete data are collected on the occurrence of potentially recurrent events through periodic monitoring. In particular, events are assumed to arise according to a point process, but information is available at the times of moni

THE ROLE OF META-ANALYSIS IN MONITORING
โœ COLIN B. BEGG ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 665 KB

The randomized clinical trial is the gold standard methodology for evaluating treatment interventions. The randomized trial is a prospective experimental study, the embodiment of the scientific method applied to the clinic. Both organizational and ethical considerations encourage the use of formal c

META-ANALYSIS IN THE DESIGN AND MONITORI
โœ REBECCA DERSIMONIAN ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 828 KB

Results from external studies often play an important role in many aspects of a clinical trial. Their incorporation into the decision making process of a trial, however, is rarely conducted in a formal manner. This conference will address what formal role, if any, meta-analytic summaries of external